agilon health, inc. (NYSE:AGL) Shares Sold by Corebridge Financial Inc.

Corebridge Financial Inc. lowered its position in agilon health, inc. (NYSE:AGL) by 7.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 153,375 shares of the company’s stock after selling 11,577 shares during the period. Corebridge Financial Inc.’s holdings in agilon health were worth $291,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently bought and sold shares of AGL. Oak Thistle LLC purchased a new stake in shares of agilon health in the 4th quarter valued at $25,000. Ieq Capital LLC acquired a new position in agilon health during the fourth quarter valued at $26,000. Signaturefd LLC lifted its position in agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock valued at $27,000 after purchasing an additional 8,467 shares during the period. Raymond James Financial Inc. purchased a new stake in agilon health in the fourth quarter valued at $33,000. Finally, Symphony Financial Services Inc. grew its position in agilon health by 44.3% during the 4th quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company’s stock worth $44,000 after purchasing an additional 7,058 shares during the period.

agilon health Trading Up 6.5 %

Shares of agilon health stock opened at $5.52 on Friday. The firm’s 50-day moving average price is $3.94 and its 200 day moving average price is $3.06. agilon health, inc. has a twelve month low of $1.50 and a twelve month high of $7.73. The firm has a market capitalization of $2.27 billion, a PE ratio of -5.87 and a beta of 0.38. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

Wall Street Analyst Weigh In

AGL has been the subject of several analyst reports. Stifel Nicolaus boosted their price objective on agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a report on Wednesday, February 26th. Royal Bank of Canada boosted their price target on agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a report on Wednesday, February 26th. Needham & Company LLC reaffirmed a “hold” rating on shares of agilon health in a research note on Friday, March 21st. Sanford C. Bernstein upgraded shares of agilon health from a “market perform” rating to an “outperform” rating and boosted their target price for the company from $3.30 to $8.50 in a research note on Tuesday. Finally, Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and raised their price target for the company from $1.75 to $2.25 in a research report on Friday, January 10th. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $4.37.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.